Lamotrigine Subacute Cutaneous Lupus Erythematous
Objective: Lamotrigine is a new generation anticonvulsant, also used in bipolar type 1 disorders to prevent occurrence of mood episodes not responding to traditional antidepressant, which is an increasing indication worldwide.
Pizzatti L +3 more
core
Review of presentations at the 6th European Lupus Meeting 3-5 March 2005. [PDF]
The 6th European Lupus Meeting was held at the Royal College of Physicians of London and was attended by 450 delegates. The conference brought together leading speakers from Europe and North America who reviewed current knowledge and exciting new ...
Rahman, A +3 more
core
Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions
Leflunomide is an immunosuppressive agent that acts by inhibiting pyrimidine synthesis in lymphocytes and other rapidly proliferating cells, as well as by suppressing tumor necrosis factor-alpha-induced cellular responses. A number of leflunomide-related
M. Barbareschi +4 more
core +1 more source
Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccination. [PDF]
Wang WY, Yu S, Hu SC.
europepmc +1 more source
Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination. [PDF]
Rimmer S, Ly L, Boh E.
europepmc +1 more source
The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus-A Pilot Study. [PDF]
Király Z +5 more
europepmc +1 more source
Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report. [PDF]
Xu K +6 more
europepmc +1 more source
Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine. [PDF]
Joseph AK, Chong BF.
europepmc +1 more source
Identification of Significant Genes and Pathways for the Chronic and Subacute Cutaneous Lupus Erythematosus via Bioinformatics Analysis. [PDF]
Teng Y +7 more
europepmc +1 more source

